PL2227467T3 - Pochodne izoksazolo-pirydyny - Google Patents

Pochodne izoksazolo-pirydyny

Info

Publication number: PL2227467T3
Authority: PL; Poland
Prior art keywords: isoxazolo; pyridine derivatives; pyridine; derivatives
Prior art date: 2007-12-04

Application number

PL08857137T

Other languages

English (en)

Inventor

Bernd Buettelmann

Roland Jakob-Roetne

Henner Knust

Matthew C Lucas

Andrew Thomas

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-04

Filing date

2008-11-26

Publication date

2015-05-29

2008-11-26 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2015-05-29 Publication of PL2227467T3 publication Critical patent/PL2227467T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL08857137T 2007-12-04 2008-11-26 Pochodne izoksazolo-pirydyny PL2227467T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP07122240		2007-12-04
PCT/EP2008/066225 WO2009071476A1 (en)	2007-12-04	2008-11-26	Isoxazolo-pyridine derivatives
EP08857137.7A EP2227467B1 (en)	2007-12-04	2008-11-26	Isoxazolo-pyridine derivatives

Publications (1)

Publication Number	Publication Date
PL2227467T3 true PL2227467T3 (pl)	2015-05-29

Family

ID=40329314

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL14168581T PL2767536T3 (pl)	2007-12-04	2008-11-26	Pochodne izoksazolo-pirydyny
PL08857137T PL2227467T3 (pl)	2007-12-04	2008-11-26	Pochodne izoksazolo-pirydyny

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL14168581T PL2767536T3 (pl)	2007-12-04	2008-11-26	Pochodne izoksazolo-pirydyny

Country Status (33)

Country	Link
US (6)	US20090143371A1 (pl)
EP (2)	EP2227467B1 (pl)
JP (1)	JP5301557B2 (pl)
KR (2)	KR101237576B1 (pl)
CN (1)	CN101889010B (pl)
AR (1)	AR069523A1 (pl)
AU (1)	AU2008333326B2 (pl)
BR (1)	BRPI0820112B8 (pl)
CA (1)	CA2707648C (pl)
CL (1)	CL2008003591A1 (pl)
CO (1)	CO6351788A2 (pl)
CR (1)	CR11454A (pl)
CY (2)	CY1116119T1 (pl)
DK (2)	DK2227467T3 (pl)
EC (1)	ECSP10010230A (pl)
ES (2)	ES2550994T3 (pl)
HR (2)	HRP20150348T1 (pl)
HU (1)	HUE025545T2 (pl)
IL (1)	IL205759A (pl)
MA (1)	MA31865B1 (pl)
MX (1)	MX2010005717A (pl)
MY (1)	MY156747A (pl)
NZ (1)	NZ585308A (pl)
PE (2)	PE20091073A1 (pl)
PL (2)	PL2767536T3 (pl)
PT (2)	PT2227467E (pl)
RS (2)	RS53877B1 (pl)
RU (1)	RU2484091C2 (pl)
SI (2)	SI2227467T1 (pl)
TW (1)	TWI363624B (pl)
UA (1)	UA100132C2 (pl)
WO (1)	WO2009071476A1 (pl)
ZA (1)	ZA201003631B (pl)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT2227467E (pt)	2007-12-04	2015-03-02	Hoffmann La Roche	Derivados de isoxazol-piridina
NZ592603A (en) *	2008-10-21	2013-02-22	Metabolex Inc	Aryl gpr120 receptor agonists and uses thereof
EP2942346B1 (en)	2009-02-17	2020-05-06	Syntrix Biosystems, Inc.	Pyridinecarboxamides as cxcr2 modulators
US8389550B2 (en) *	2009-02-25	2013-03-05	Hoffmann-La Roche Inc.	Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) *	2009-04-02	2012-07-17	Hoffmann-La Roche Inc.	Substituted isoxazoles
US20100280019A1 (en) *	2009-04-30	2010-11-04	Roland Jakob-Roetne	Isoxazoles
MX2011011273A (es) *	2009-05-05	2011-11-04	Hoffmann La Roche	Derivados de isoxazol-pirazol.
CA2759598C (en) *	2009-05-05	2017-09-12	F. Hoffmann-La Roche Ag	Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
AU2010244553A1 (en) *	2009-05-05	2011-12-01	F. Hoffmann-La Roche Ag	Isoxazole-pyridine derivatives
ES2430223T3 (es) *	2009-05-07	2013-11-19	F. Hoffmann-La Roche Ag	Derivados de isoxazol-piridina como moduladores de GABA
EP2482657A4 (en) *	2009-09-21	2013-05-15	Univ Vanderbilt	O-BENZYL-NICOTINAMIDANALOGA AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS
KR20120117905A (ko)	2010-01-28	2012-10-24	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	프로테아좀 활성을 향상시키는 조성물 및 방법
BR112013001237A2 (pt)	2010-07-19	2016-05-17	Syngenta Participations Ag	compostos de isoxazola, isoatiazola, furano e tiofeno como microbicidas
CN103003265A (zh)	2010-07-19	2013-03-27	先正达参股股份有限公司	杀微生物剂
WO2012027289A1 (en)	2010-08-23	2012-03-01	Syntrix Biosystems Inc.	Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators
EP2635277B1 (en) *	2010-11-05	2018-12-19	F.Hoffmann-La Roche Ag	Use of active pharmaceutical compounds for the treatment of central nervous system conditions
EP2457569A1 (en)	2010-11-05	2012-05-30	F. Hoffmann-La Roche AG	Use of active pharmaceutical compounds for the treatment of central nervous system conditions
PT2707101T (pt)	2011-05-12	2019-05-30	Proteostasis Therapeutics Inc	Reguladores da proteostase
US8604062B2 (en) *	2011-10-20	2013-12-10	Hoffman-La Roche Inc.	Process for the preparation of isoxazolyl-methoxy nicotinic acids
US8785435B2 (en) *	2011-10-20	2014-07-22	Hoffmann-La Roche Inc.	Solid forms
JP6242810B2 (ja)	2011-12-28	2017-12-06	グローバル・ブラッド・セラピューティクス・インコーポレイテッドＧｌｏｂａｌＢｌｏｏｄＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	置換ベンズアルデヒド化合物および組織酸素化の増加におけるそれらの使用方法
WO2013102145A1 (en) *	2011-12-28	2013-07-04	Global Blood Therapeutics, Inc.	Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain
WO2014001279A1 (en)	2012-06-26	2014-01-03	Aniona Aps	A phenyl triazole derivative and its use for modulating the gabaa receptor complex
US9206160B2 (en)	2012-06-26	2015-12-08	Saniona Aps	Phenyl triazole derivative and its use for modulating the GABAA receptor complex
WO2014001280A1 (en)	2012-06-26	2014-01-03	Aniona Aps	A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001282A1 (en)	2012-06-26	2014-01-03	Aniona Aps	A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001278A1 (en)	2012-06-26	2014-01-03	Aniona Aps	A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014116228A1 (en)	2013-01-25	2014-07-31	President And Fellows Of Harvard College	Usp14 inhibitors for treating or preventing viral infections
US10100043B2 (en)	2013-03-15	2018-10-16	Global Blood Therapeutics, Inc.	Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US10266551B2 (en)	2013-03-15	2019-04-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
CN105246477A (zh)	2013-03-15	2016-01-13	全球血液疗法股份有限公司	化合物及其用于调节血红蛋白的用途
US9604999B2 (en)	2013-03-15	2017-03-28	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en)	2013-03-15	2016-10-04	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en)	2013-03-15	2016-08-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
EA037091B1 (ru)	2013-03-15	2021-02-04	Глобал Блад Терапьютикс, Инк.	Соединения и их применения для модуляции гемоглобина
MX379228B (es)	2013-03-15	2025-03-10	Global Blood Therapeutics Inc	Compuestos y usos de estos para la modulación de la hemoglobina.
US20140274961A1 (en)	2013-03-15	2014-09-18	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en)	2013-03-15	2017-10-31	Global Blood Therapeutics, Inc.	Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en)	2013-03-15	2015-02-10	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
EP2792360A1 (en)	2013-04-18	2014-10-22	IP Gesellschaft für Management mbH	(1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV
US10561676B2 (en)	2013-08-02	2020-02-18	Syntrix Biosystems Inc.	Method for treating cancer using dual antagonists of CXCR1 and CXCR2
US10046002B2 (en)	2013-08-02	2018-08-14	Syntrix Biosystems Inc.	Method for treating cancer using chemokine antagonists
US8969365B2 (en)	2013-08-02	2015-03-03	Syntrix Biosystems, Inc.	Thiopyrimidinecarboxamides as CXCR1/2 modulators
WO2015073528A1 (en)	2013-11-12	2015-05-21	Proteostasis Therapeutics, Inc.	Proteasome activity enhancing compounds
EA201992707A1 (ru)	2013-11-18	2020-06-30	Глобал Блад Терапьютикс, Инк.	Соединения и их применения для модуляции гемоглобина
CN114213390A (zh)	2014-02-07	2022-03-22	全球血液疗法股份有限公司	一种化合物的结晶多晶型物
JP2017071553A (ja) *	2014-02-25	2017-04-13	味の素株式会社	ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
MA41841A (fr)	2015-03-30	2018-02-06	Global Blood Therapeutics Inc	Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
CN106810542B (zh) *	2015-11-30	2021-03-09	苏州开拓药业股份有限公司	一种硫代咪唑烷酮化合物的晶型、盐型及其制备方法
FI3383392T3 (fi)	2015-12-04	2025-09-11	Global Blood Therapeutics Inc	Annosteluohjelmat 2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydille
TWI752307B (zh)	2016-05-12	2022-01-11	美商全球血液治療公司	新穎化合物及製造化合物之方法
TWI778983B (zh)	2016-10-12	2022-10-01	美商全球血液治療公司	包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US10660909B2 (en)	2016-11-17	2020-05-26	Syntrix Biosystems Inc.	Method for treating cancer using chemokine antagonists
MY200641A (en) *	2016-12-08	2024-01-08	Hoffmann La Roche	New isoxazolyl ether derivatives as gaba a alpha5 pam
BR112020004116A2 (pt) *	2017-08-28	2020-09-01	University Of Maryland, Baltimore	novos moduladores do receptor de ácido gama aminobutírico tipo a para distúrbios de humor
UY38031A (es) *	2017-12-22	2019-07-31	Bayer Ag	Hidroxiisoxazolinas y derivados de estos
MX2020013518A (es) *	2018-06-13	2021-02-26	Hoffmann La Roche	Nuevos derivados de isoxazolil eter como moduladores alostericos positivos (pam) del receptor de acido gamma-aminobutirico a alfa5 (gaba a alfa5).
BR102019014802A2 (pt)	2018-07-20	2020-02-04	Boehringer Ingelheim Int	difluorometil-fenil triazóis
HU231223B1 (hu)	2018-09-28	2022-01-28	Richter Gedeon Nyrt.	GABAA A5 receptor modulátor hatású biciklusos vegyületek
WO2020072377A1 (en)	2018-10-01	2020-04-09	Global Blood Therapeutics, Inc.	Modulators of hemoglobin for the treatment of sickle cell disease
WO2020163689A1 (en)	2019-02-08	2020-08-13	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	20-hete formation inhibitors
WO2021191837A1 (en)	2020-03-26	2021-09-30	Richter Gedeon Nyrt.	1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa α5 receptor modulators
CA3216863A1 (en)	2021-05-05	2022-11-10	University College Cardiff Consultants Limited	Heteroaryl compounds useful in the treatment of cognitive disorders
CN116854680A (zh) *	2022-03-28	2023-10-10	上海赛默罗生物科技有限公司	异噁唑-杂环类衍生物、药物组合物和用途
CN115286636A (zh) *	2022-10-08	2022-11-04	上海赛默罗生物科技有限公司	烟酰胺晶型及其制备方法和用途
TW202448433A (zh) *	2023-06-05	2024-12-16	大陸商武漢人福創新藥物研發中心有限公司	作為α5-GABAA受體調節劑的雜環化合物及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3812225A1 (de) *	1988-04-13	1989-10-26	Basf Ag	Isoxazol(isothiazol)-5-carbonsaeureamide
ATE315033T1 (de)	1998-08-07	2006-02-15	Chiron Corp	Subtituierte isoxazole derivate als estrogen rezeptor modulatore
DE19920791A1 (de) *	1999-05-06	2000-11-09	Bayer Ag	Substituierte Benzoylisoxazole
GB0125086D0 (en)	2001-10-18	2001-12-12	Merck Sharp & Dohme	Novel compounds
WO2003099793A1 (en)	2002-05-24	2003-12-04	Takeda Pharmaceutical Company Limited	1,2-azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) *	2002-09-16	2002-10-23	Glaxo Group Ltd	Pyridine derivates
MXPA06013196A (es) *	2004-05-14	2007-02-14	Irm Llc	Compuestos y composiciones como moduladores del receptor activado por proliferador de peroxisoma (ppar).
ES2315912T3 (es) *	2004-10-01	2009-04-01	F. Hoffmann-La Roche Ag	Derivados de eter sustituido por hexafluorisopropanol.
US7700620B2 (en) *	2005-06-27	2010-04-20	Bristol-Myers Squibb Company	C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
AU2006298867A1 (en) *	2005-09-19	2007-04-12	F. Hoffmann-La Roche Ag	Isoxazolo derivatives as GABA A alpha5 inverse agonists
CA2625301A1 (en) *	2005-10-11	2007-04-19	F. Hoffmann-La Roche Ag	Isoxazole derivatives
EP1968972B1 (en) *	2005-12-23	2012-11-28	F. Hoffmann-La Roche AG	Aryl-isoxazolo-4-yl-oxadiazole derivatives
BRPI0620760A2 (pt)	2005-12-27	2011-11-22	Hoffmann La Roche	derivados de aril-isoxazol-4-il-imidazo[1,5]piridina
WO2007074078A2 (en)	2005-12-27	2007-07-05	F. Hoffmann-La Roche Ag	Aryl-isoxazol-4-yl-imidazole derivatives
AU2007207053B2 (en)	2006-01-17	2012-05-24	F. Hoffmann-La Roche Ag	Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
CA2706990C (en)	2007-12-04	2016-05-10	F. Hoffmann-La Roche Ag	Isoxazolo-pyrazine derivatives
US7943619B2 (en)	2007-12-04	2011-05-17	Hoffmann-La Roche Inc.	Isoxazolo-pyridazine derivatives
PT2227467E (pt)	2007-12-04	2015-03-02	Hoffmann La Roche	Derivados de isoxazol-piridina
US20100280019A1 (en) *	2009-04-30	2010-11-04	Roland Jakob-Roetne	Isoxazoles

2008
- 2008-11-26 PT PT08857137T patent/PT2227467E/pt unknown
- 2008-11-26 EP EP08857137.7A patent/EP2227467B1/en active Active
- 2008-11-26 NZ NZ585308A patent/NZ585308A/en unknown
- 2008-11-26 UA UAA201008007A patent/UA100132C2/ru unknown
- 2008-11-26 SI SI200831370T patent/SI2227467T1/sl unknown
- 2008-11-26 CA CA2707648A patent/CA2707648C/en active Active
- 2008-11-26 ES ES14168581.8T patent/ES2550994T3/es active Active
- 2008-11-26 PT PT141685818T patent/PT2767536E/pt unknown
- 2008-11-26 RU RU2010123923/04A patent/RU2484091C2/ru active
- 2008-11-26 BR BRPI0820112A patent/BRPI0820112B8/pt active IP Right Grant
- 2008-11-26 SI SI200831532T patent/SI2767536T1/sl unknown
- 2008-11-26 HR HRP20150348TT patent/HRP20150348T1/hr unknown
- 2008-11-26 DK DK08857137.7T patent/DK2227467T3/en active
- 2008-11-26 CN CN2008801193998A patent/CN101889010B/zh active Active
- 2008-11-26 AU AU2008333326A patent/AU2008333326B2/en active Active
- 2008-11-26 PL PL14168581T patent/PL2767536T3/pl unknown
- 2008-11-26 KR KR1020107012058A patent/KR101237576B1/ko active Active
- 2008-11-26 ES ES08857137T patent/ES2531023T3/es active Active
- 2008-11-26 HU HUE14168581A patent/HUE025545T2/en unknown
- 2008-11-26 MY MYPI2010002566A patent/MY156747A/en unknown
- 2008-11-26 PL PL08857137T patent/PL2227467T3/pl unknown
- 2008-11-26 JP JP2010536409A patent/JP5301557B2/ja active Active
- 2008-11-26 MX MX2010005717A patent/MX2010005717A/es active IP Right Grant
- 2008-11-26 EP EP14168581.8A patent/EP2767536B1/en active Active
- 2008-11-26 RS RS20150176A patent/RS53877B1/sr unknown
- 2008-11-26 WO PCT/EP2008/066225 patent/WO2009071476A1/en not_active Ceased
- 2008-11-26 KR KR1020127018310A patent/KR20120102117A/ko not_active Withdrawn
- 2008-11-26 DK DK14168581.8T patent/DK2767536T3/en active
- 2008-11-26 RS RS20150703A patent/RS54355B1/sr unknown
- 2008-12-01 PE PE2008002002A patent/PE20091073A1/es active IP Right Grant
- 2008-12-01 US US12/325,293 patent/US20090143371A1/en not_active Abandoned
- 2008-12-01 TW TW097146632A patent/TWI363624B/zh active
- 2008-12-01 PE PE2012002214A patent/PE20130242A1/es not_active Application Discontinuation
- 2008-12-02 AR ARP080105242A patent/AR069523A1/es active IP Right Grant
- 2008-12-02 CL CL2008003591A patent/CL2008003591A1/es unknown
2010
- 2010-05-13 IL IL205759A patent/IL205759A/en active IP Right Grant
- 2010-05-14 CO CO10058230A patent/CO6351788A2/es active IP Right Grant
- 2010-05-21 ZA ZA2010/03631A patent/ZA201003631B/en unknown
- 2010-05-21 CR CR11454A patent/CR11454A/es unknown
- 2010-05-27 MA MA32871A patent/MA31865B1/fr unknown
- 2010-06-03 EC EC2010010230A patent/ECSP10010230A/es unknown
2012
- 2012-02-10 US US13/370,444 patent/US8518974B2/en active Active
2013
- 2013-06-12 US US13/916,068 patent/US8846719B2/en active Active
- 2013-06-12 US US13/916,264 patent/US8877783B2/en active Active
- 2013-06-12 US US13/916,317 patent/US9073908B2/en active Active
- 2013-06-12 US US13/916,191 patent/US8877782B2/en active Active
2015
- 2015-03-16 CY CY20151100262T patent/CY1116119T1/el unknown
- 2015-11-09 CY CY20151100999T patent/CY1116902T1/el unknown
- 2015-11-20 HR HRP20151250TT patent/HRP20151250T1/hr unknown

Also Published As

Publication number	Publication date
CA2707648C (en)	2014-08-12
US8518974B2 (en)	2013-08-27
TWI363624B (en)	2012-05-11
BRPI0820112A2 (pt)	2015-05-05
HRP20151250T1 (hr)	2015-12-18
US8877783B2 (en)	2014-11-04
HRP20150348T1 (hr)	2015-05-08
AU2008333326A1 (en)	2009-06-11
CN101889010A (zh)	2010-11-17
PL2767536T3 (pl)	2016-01-29
TW200924763A (en)	2009-06-16
PT2227467E (pt)	2015-03-02
RS54355B1 (sr)	2016-04-28
US20130281690A1 (en)	2013-10-24
US20130274468A1 (en)	2013-10-17
JP5301557B2 (ja)	2013-09-25
MX2010005717A (es)	2010-06-02
EP2227467A1 (en)	2010-09-15
HK1149756A1 (en)	2011-10-14
CA2707648A1 (en)	2009-06-11
PT2767536E (pt)	2015-11-17
CY1116119T1 (el)	2017-02-08
ES2550994T3 (es)	2015-11-13
EP2227467B1 (en)	2014-12-31
US8877782B2 (en)	2014-11-04
AU2008333326B2 (en)	2013-05-30
CR11454A (es)	2010-06-28
ZA201003631B (en)	2013-10-30
KR101237576B1 (ko)	2013-03-04
US20120184538A1 (en)	2012-07-19
ES2531023T3 (es)	2015-03-09
NZ585308A (en)	2012-03-30
PE20130242A1 (es)	2013-03-04
UA100132C2 (en)	2012-11-26
IL205759A0 (en)	2010-11-30
US8846719B2 (en)	2014-09-30
RU2010123923A (ru)	2012-01-10
BRPI0820112B1 (pt)	2019-01-15
EP2767536A1 (en)	2014-08-20
US20090143371A1 (en)	2009-06-04
US20130274469A1 (en)	2013-10-17
WO2009071476A1 (en)	2009-06-11
CN101889010B (zh)	2012-12-05
US9073908B2 (en)	2015-07-07
CY1116902T1 (el)	2017-04-05
RU2484091C2 (ru)	2013-06-10
ECSP10010230A (es)	2010-07-30
US20130274467A1 (en)	2013-10-17
JP2011505401A (ja)	2011-02-24
PE20091073A1 (es)	2009-07-23
DK2227467T3 (en)	2015-01-19
AR069523A1 (es)	2010-01-27
DK2767536T3 (en)	2015-10-19
BRPI0820112B8 (pt)	2021-05-25
SI2767536T1 (sl)	2015-12-31
HUE025545T2 (en)	2016-03-29
KR20120102117A (ko)	2012-09-17
SI2227467T1 (sl)	2015-03-31
EP2767536B1 (en)	2015-09-02
MY156747A (en)	2016-03-31
CL2008003591A1 (es)	2010-01-04
IL205759A (en)	2014-07-31
KR20100075669A (ko)	2010-07-02
CO6351788A2 (es)	2011-12-20
RS53877B1 (sr)	2015-08-31
MA31865B1 (fr)	2010-11-01

Publication	Publication Date	Title
HUS2400041I1 (hu)	2024-12-28	4-Pirimidin-szulfamid-származék
ZA201003631B (en)	2013-10-30	Isoxazolo-pyridine derivatives
IL205753A0 (en)	2010-11-30	Isoxazolo-pyridazine derivatives
IL202020A0 (en)	2010-06-16	Spiroindolinone derivatives
ZA201001058B (en)	2010-11-24	Quinazolinamide derivatives
IL202830A0 (en)	2010-06-30	Indazolamide derivatives
ZA200908298B (en)	2010-08-25	Bicycloaniline derivative
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
IL205755A0 (en)	2010-11-30	Isoxazolo-pyrazine derivatives
PL2308877T3 (pl)	2014-07-31	Pochodne imidazopirydyn-2-onu
IL200618A0 (en)	2010-05-17	Aza-pyridopyrimidinone derivatives
IL210406A0 (en)	2011-03-31	Pyrrolopyridinylpyrimidin - 2 - ylamine derivatives
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
IL202667A0 (en)	2010-06-30	Isoxazole-imidazole derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
IL213424A0 (en)	2011-07-31	Quinazolinamide derivatives
EP2163554A4 (en)	2010-12-15	PYRIMIDODIAZEPINONE DERIVATIVE
PL2245028T3 (pl)	2012-07-31	Pochodne 5-aminocyklilometyloksazolidyn-2-onu
EP2133347A4 (en)	2010-03-17	1-BIARYLAZETIDINONDERIVATE
IL202463A0 (en)	2010-06-30	Sulfonyl-quinoline derivatives
IL202159A0 (en)	2010-06-16	Piperidine-amide derivatives
EP2228362A4 (en)	2011-10-12	4-HYDROXYPHENYLALKYLAMINE DERIVATIVE
ZA201002218B (en)	2010-12-29	Thiadiazinone derivatives
ZA201000311B (en)	2010-10-27	Sulfonyl-quinoline derivatives